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Purpose: To compare success rates of external dacryocystorhinostomy (DCR) and endoscopic 
endonasal DCR for acquired nasolacrimal duct obstruction (NLDO).
Design: Historical cohort study.
Participants: 100 patients who underwent external DCR and 105 patients who underwent 
endoscopic endonasal DCR.
Methods: A retrospective review of medical records of patients with acquired NLDO who 
underwent DCR from 2004–2010 was performed. Data regarding the lacrimal drainage system, 
eye examination, surgical outcomes, patient symptom control, and postoperative care were 
analyzed.
Main outcome measures: Surgical success was defined by patient’s resolution of symptoms 
with patency on irrigation. Surgical failure was defined as no symptomatic reduction in epiphora 
and/or an inability to irrigate the lacrimal system postoperatively.
Results: A total of 205 patients underwent surgeries for acquired NLDO. The average age 
was 69 years, and 62.4% of subjects were female. Pooled results showed that both surgical 
approaches had similar success rates (endoscopic endonasal DCR 82.4% versus external DCR 
81.6%; P = 0.895). Complication rates were low in both types of surgery. This included three 
patients with postoperative hemorrhage (two who had endonasal DCR surgery and one having 
external DCR surgery). This resolved with conservative treatment. Postoperative problems with 
lacrimal patency (including canalicular obstruction) occurred to 6.8% of endoscopic patients 
and 9% of those with the external DCR surgery. Of the 14 patients who had their silicone tubes 
fall out before the 2-month assessment, 10 were classified as failures (71%), in contrast to only 
a failure rate of 13.9% of those whose tubes were present for the recommended time. This dif-
ference was statistically significant (P , 0.01).
Conclusion: The success rate of DCR for acquired NLDO in our group of patients was high   
overall with a low complication rate between the two types of surgery. There was no statistically 
significant difference between endoscopic and external DCR. Endoscopic surgery may have a 
benefit of preserving the lacrimal pump system and leaving no surgical scar. Patient preference 
and availability of each service should direct management. Hence endoscopic endonasal DCR 
surgery should be considered for primary treatment of nasolacrimal duct obstruction.
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Introduction
Standard treatment for nasolacrimal duct obstruction has been dacryocystorhinostomy 
(DCR) surgery. The external approach is performed through a cutaneous incision to 
access the lacrimal sac. The procedure gained popularity due to its efficacy and rela-
tively low complication rates. Endoscopic endonasal DCR has gathered   momentum Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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with direct visualization under endoscopic guidance. 
Caldwell first introduced the endonasal approach for lacri-
mal surgery in 1893. However endoscopic endonasal DCR 
has only become recently employed with new endoscopy 
instruments and technique.1 This approach avoids an external 
scar and neurovascular disruption along the tract exposing 
the lacrimal sac.
The reported success rates of both procedures range 
from 63% to 97%.2–4 The wide range of success is likely 
due to surgical variability, patient demographics, and lack 
of standardized outcome measures in the medical literature. 
The purpose of the current study was to evaluate both the 
functional/anatomic success as well as symptom control for 
endoscopic endonasal and external DCR surgeries performed 
at two specialized centers.
Methods
Medical records were reviewed in all patients who underwent 
surgery for acquired nasolacrimal duct obstruction (NLDO) 
from January 2004 to May 2010. The study was carried out 
in accordance with the ethical guidelines of the Declaration 
of Helsinki with institutional ethical approval. Data was col-
lected in a spreadsheet with a standard collection template 
used for both types of operations.
A diagnosis of NLDO was made from ophthalmic exami-
nation and/or radiological findings. All patients included had 
symptoms of epiphora. Documented obstruction on syringing 
and probing or obstruction on lacrimal scintigraphy were 
used in the diagnosis of NLDO.
Patients with previous DCR surgery to the same eye 
were excluded from the study. Refer to Table 1 for selection 
criteria for nasolacrimal duct obstruction.
Surgery choice of external or endoscopic endonasal DCR 
was based on hospital or day surgery attended. All operations 
at the two eye centers were performed by one of the authors 
(RG). All patients who had the external DCR surgery held 
private health insurance. The endonasal endoscopic DCRs 
were performed at a public hospital. This is a weakness of 
the study.
Patients underwent ophthalmic examinations including 
irrigation of the nasolacrimal drainage systems, fluorescein 
dye disappearance test, and intranasal examination. All 
patients had tubes inserted intra-operatively.
Standard external approach was used. Endoscopic 
endonasal DCR surgery consisted of adequate lacrimal sac 
exposure and creation of a large marsupialized lacrimal sac, 
covering the exposed bone with preserved nasal mucosal 
flaps.
Postoperatively, the silicone tube was removed after 
1–2 months. In 14 patients, the tubes fell out early, and 
four patients had their tubes in situ for more than 4 months. 
Irrigation of the nasolacrimal systems and fluorescein dye 
disappearance test was performed at postoperative follow-up 
appointments in all patients.
Postoperatively, all patients were assessed within 1 month 
of surgery. Patient follow-up included 2 months follow-up for 
tube assessment and subsequent 4–12-month follow-up for 
progress and symptom surveillance. During postoperative 
visits, patients were asked about symptomatic resolution of 
epiphora and assessed with patency on irrigation, fluroscein 
dye disappearance test, and intranasal examination. Postopera-
tive complications were also noted at each visit. All patients 
were followed up for at least 6 months (range 6–24 months).
Results were defined by patient’s resolution of symp-
toms with patency on irrigation and a positive fluorescein 
dye disappearance test. Patients’ resolution of symptoms 
were stratified into four categories during data collection. 
These were: 1) no epiphora and complete resolution of 
symptoms; 2) improved epiphora with associated patient 
satisfaction, with no further follow-up required; 3) continued 
epiphora with no improvement; and 4) revision DCR surgery 
required with or without Jones tubes. Only patients with 
patency on irrigation of the lacrimal system and a negative 
fluorescein dye disappearance test postoperatively could be 
classified into categories 1 and 2.
Outcome measures were pooled in order to determine 
success or failure. Patients who were categorized 1 and 2 with 
patency on irrigation were defined as a successful outcome. 
Patients were also categorized as surgical failure if they 
experienced any postoperative episode of dacryocystitis. 
Inability to irrigate the lacrimal system postoperatively, nasal 
endoscopy with scarring at the intranasal osteotomy, and/or 
no visualization of fluorescein dye was also classified as a 
surgical failure. It can be noted that patients with improved 
or resolved symptoms but with postoperative obstruction 
on irrigation were still classified as surgical failure. Refer 
to Table 2 for outcome measures.
Table 1 selection criteria for cases with nLDO
Inclusion Exclusion
epiphora Previous DCr to same eye
evidence of obstruction  
on probing and irrigation  
Fluorescein dye disappearance test
Congenital nLDO
Obstruction on lacrimal scintigraphy Age under 16 years
Abbreviations:  DCr,  dacryocystorhinostomy;  nLDO,  nasolacrimal  duct 
obstruction.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Patient demographic data was collected, including age, 
gender, date of birth, ethic origin, and language. Refer to 
Table 3 for baseline characteristics stratified by endonasal 
endoscopic and external DCR surgery.
surgical technique
endoscopic endonasal DCr
Endoscopic endonasal DCR was performed under general 
anesthesia. After vasoconstriction of the nasal cavity by 
neurosurgical pledges soaked in cocaine, the head of the 
middle turbinate and the mucosa surrounding the lacrimal 
sac are infiltrated with a (lignocaine and lidocaine combi-
nation) local anesthetic. The dose of local anesthetic was 
not recorded in the data template. A surgical incision is 
made at the lateral nasal wall, anterior superior to the inser-
tion of the middle turbinate. The posterior mucosal flap is 
elevated off the maxillary bone and incision made until the 
sac is exposed. Metallic lacrimal probes are passed medi-
ally through both canaliculi so as to tent the sac lumen. By 
preserving the nasal submucosal injection in the presumed 
lacrimal fossa during opening of the sac, marsupializa-
tion can occur to appose the nasal mucosa. A silicone 
bicanalicular tube is then positioned and tied. All patients 
were given postoperative chloramphenicol and prednisone 
drops to the affected eye four times a day for a month as 
well as oral cephalosporin. Medication variation was only 
considered if the patient had a known allergy. Patients are 
encouraged to wash using nasal rinse or sprays to prevent 
crust formation.
external
External DCR was performed under local anesthetic. Some 
patients were sedated for the duration of the procedure. A 
straight incision is made medially to the angular vein at the 
level of the medial canthal ligament. The wound is opened 
with traction sutures for adequate exposure of the anterior 
lacrimal crest. An osteotomy is created and lacrimal sac and 
musoca opened to form anterior and posterior flaps. Probing 
ensures site of obstruction is localized, then flaps sutured 
with 6/0 vicryls sutures. A silicon tube is inserted and tied. 
The wound is closed and skin is sutured using fine sutures 
for cosmetic effect. All patients were given chlorampheni-
cal and prednisilone eye drops four times a day for a month 
postoperatively. The tubes were kept in situ for a minimum 
duration of 2 months before removal.
statistical analysis
Independent-samples t-test and χ²-nonparametric analysis 
were used to compare numerical variables and propor-
tions, respectively, between successful and failed cases 
and between endoscopic and external DCRs. Significance 
testing was carried out on patient demographics, ocular his-
tory, comorbidities and symptoms, peri and postoperative 
outcomes and follow up. Outcomes measures were pooled 
with assessment of statistical significance. SPSS program 
was used for the statistical analysis.
Results
A total of 205 patients were included in the study (128 females 
and 77 males), with a mean age of 69 years.   Demographics 
between the two surgical groups were similar. There was no 
statistically significant difference in comorbidities, previ-
ous sinus disease or surgery, ocular history, or presenting 
symptoms. There was a statistically significant difference 
in the ethnic origin, with more Caucasians in the external 
DCR group than the endoscopic endonasal group (see 
Table 3).
Multivariate analysis was not performed, as the majority 
of the groups’ characteristics were statistically similar apart 
from intervention.
The operation was classified as successful by the objective 
demonstration of a patent nasolacrimal system through irri-
gation. Patency was achieved in 96 (93.2%) of 103 patients 
for the endonasal DCR and 83 (91.2%) of 91 patients for 
external DCR surgery (refer to Table 4). The difference was 
not statistically significant (P = 0.604).
Anatomical patency and symptom relief (6–24 months 
postoperatively) was achieved in 84 (82.4%) of 102 patients 
in the endonasal DCR group and 80 (81.6%) of 98 patients 
in the external DCR group (Table 4). This difference was not 
statistically significant (P = 0.895). Refer to Table 5 for 
results of success stratified by DCR surgery, endonasal and 
external.
The complication incidence was low and similar in both 
operations. Three patients had postoperative hemorrhage 
Table 2 Outcome measures for cases post dacryocystorhino-
stomy surgery
Success Failure
Patency on probing and irrigation Obstruction on probing and  
irrigation
resolution of symptoms Ostial scarring
improvement of symptoms No visualization of fluorescein   
in dye disappearance test
Persistent symptoms
requiring revision or adjuvant  
interventionClinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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(two who had endonasal DCR surgery and one having 
external DCR surgery). Postoperative hemorrhage was either 
wound hemorrhage or epistaxis. All of these patients were 
treated conservatively, including nasal spray and/or packing. 
Hemostasis was achieved with no secondary hemorrhage 
resulting in surgical intervention. Canalicular obstruction was 
documented in six cases, with three in each of the surgical 
groups. There was no documented orbital and   subcutaneous 
emphysema, conjunctival fistula formation, retrobulbar 
hemorrhage, medical rectus paresis, orbital fat herniation, or 
nasal mucosal synechiae formation. See Table 6 for postop-
erative results and complications stratified by DCR surgery, 
endoscopic endonasal and external.
Fourteen patients who underwent DCR surgery had tubes 
that fell out before the 2-month assessment, of which six were 
in the endonasal group and eight in the external group. There 
Table 3 Demographics of endoscopic endonasal and external dacryocystorhinostomy groups
Categorized Total (205) Endoscopic (105) External (100) Overall P value
Age, mean (sD) 68.89 (15.022) 66.77 (17.432) 70.34 (12.829) ns
Female sex (%) 128 68 (64.8) 60 (60) 0.482
ethnicity (%) Caucasian 135 (71.4) 58 (59.2) 77 (84.6)
Oriental 20 (10.6) 12 (12.2) 8 (8.8)
indian  
subcontinent
3 (1.6) 3 (3.1) 0 (0)
european 30 (15.9) 24 (24.5) 6 (6.6)
African 1 (0.5) 1 (1) 0 (0) 0.001
nesB 29 (14.3) 20 (19.2) 9 (9.1) 0.039
Previous sinus surgery 6 (3) 2 (1.9) 4 (4.2) 0.353
history of ocular trauma  
with either nLD obstruction  
or canalicular laceration
7 (3.5) 6 (5.7) 1 (1) 0.069
Comorbidities (yes) 125 (61.6) 66 (62.9) 59 (60.2) 0.698
hT 88 (44) 47 (44.8) 41 (43.2) 0.819
DM 23 (11.5) 17 (16.2) 6 (6.3) 0.029
smoking no 170 (85) 88 (83.8) 82 (86.3)
Yes 22 (11) 9 (8.6) 13 (13.7)
ex 8 (4) 8 (7.6) 0 (0) 0.140
Ocular history no 90 (44.3) 48 (46.2) 42 (42.4)
Previous cataract  
surgery
16 (7.9) 9 (8.7) 7 (7.1)
glaucoma 9 (4.4) 1 (1) 8 (8.1)
Corneal disease 1 (0.5) 0 (0) 1 (1)
Ocular plastic 38 (18.7) 22 (21.2) 16 (16.2)
retinal 9 (4.4) 3 (2.9) 6 (6.1)
Other 8 (3.9) 2 (1.9) 6 (6.1)
More than two  
ocular conditions
32 (15.8) 19 (18.3) 13 (13.1) 0.099
epiphora 204 (100) 104 (100) 100 (100) Constant
red eyes 35 (17.2) 14 (13.6) 21 (21) 0.162
Blepharitis 38 (18.7) 21 (20.4) 17 (17) 0.536
Inflammatory eye disease 2 (1) 2 (1.9) 0 (0) 0.161
itchy eyes 42 (20.7) 17 (16.5) 25 (25) 0.135
Dacrocystitis 35 (17.5) 21 (20.6) 14 (14.3) 0.241
Conjunctivitis history 17 (8.4) 13 (12.6) 4 (4)
Antibiotic use 57 (27.9) 28 (26.9) 29 (29)
Use of lubricants greater  
than 3 months
135 (66.8) 60 (58.3) 75 (75.8) 0.008
Use of chloramphenicol  
drops
84 (41.4) 39 (37.9) 45 (45) 0.302
glasses/contacts 143 (74.1) 66 (68) 77 (80.2) 0.054
Anticoagulation
Past treatment duration  
months (sD)
32.56 (25.34) 28.2 (24.9) 37.18 (25.03) ns
Obstruction viewed 199 (100) 204 (100) 95 (100) Constant
Abbreviations: DM, diabetes mellitus; HT, hypertension; NESB, non-English speaking background; NLD, nasolacrimal duct; NS, not significant; SD, standard deviation.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
983
external and endoscopic endonasal dacryocystorhinostomy
was no statistical significance between the external DCR 
group and the endoscopic endonasal group (P = 0.44). Of 
these patients, 10 had persistent symptoms or surgical failure 
(71%). Of the 186 patients who had their tubes in situ for the 
recommended time (2 months), 26 had persistent symptoms 
or surgical failure (13.9%). This difference was statistically 
significant (P , 0.01).
No endonasal DCR operations needed conversion to 
external DCR surgery. A biopsy was required for four 
endonasal surgeries due to detection of polyps or suspicious 
lesions. One patient was found to have a nasal polyp, with 
three other biopsy results reporting inflammatory or keratotic 
lesion. The exact anatomical location of the biopsies were 
unknown.
Twenty-one patients were candidates for revision surgery: 
9 (8.8%) of 104 patients in the endonasal group, and 12 
(12.2%) of 98 patients in the external group. This difference 
was not statistically significant. The main reasons for revi-
sion surgery were persistent or worse symptoms. Endoscopic 
revision surgery was undertaken instead of a revision external 
DCR, due to surgeon and patient preference. Seven patients 
with previous external DCR underwent revision endonasal 
DCR. Patency and symptom resolution was achieved in 
four cases. Two patients had patency on probing and irriga-
tion, but persistent symptoms. One patient had repeat DCR 
surgery, with a total of three external and endonasal DCR 
to the same eye with continued persisting symptoms. Five 
patients who had previous initial endonasal DCR underwent 
revision endonasal DCR. Four out of five of these patients 
had patency on irrigation, but only two patients had resolu-
tion of symptoms, with three patients experiencing persistent 
epiphora. The discrepancy between anatomical patency and 
resolution of symptoms may be due to the lacrimal paradox 
outlined in the discussion.5–7
Discussion
External DCR surgery at the turn of the century was regarded 
as the gold standard in treatment for nasolacrimal duct 
obstruction. The case for this procedure lies in its predict-
ability of success and direct visualization of the anatomy 
compared with a nasoendoscope. However, the procedure 
leaves a cutaneous scar and the potential for injury to 
medial canthal structures, cerebrospinal fluid rhinorrhea, 
and functional interference with the physiological action of 
the lacrimal pump.8
Over the last decade, however, endoscopic DCR has 
shown equally promising results for long-term success in 
nasolacrimal duct obstruction with the benefits of minimal 
invasive surgery. Endoscopic DCR allows direct inspection 
of the lacrimal sac for underlying pathology. With an under-
standing of the intranasal anatomy, assessment and treatment 
of obstruction can be a routine procedure. The assessment 
of failures can also be viewed endoscopically. This allows 
recognised mistakes to be immediately revised at the time 
of surgery. Intranasal biopsy of suspicious mucosa can be 
taken for further assessment. The option of converting an 
endoscopic DCR to external approach during initial surgery 
Table 5 Results of success stratified by DCR surgery endoscopic endonasal and external
Results Total Endonasal DCR External DCR Overall P value
Lacrimal patency 179 (92.3) 96 (93.2) 83 (91.2) 0.604
symptoms 2 weeks  
post DCr
resolution 56 (27.7) 27 (26.2) 29 (29.3)
improved 128 (63.4) 65 (63.1) 63 (63.6)
Persistent 15 (7.4) 8 (7.8) 7 (7.1)
symptoms worse 3 (1.5) 3 (2.9) 0 (0) 0.270
Follow up months resolution 145 (72.5) 76 (74.5) 69 (70.4)
improved 19 (9.5) 8 (7.8) 11 (11.2)
Persistent 15 (7.5) 9 (8.8) 6 (6.1)
revision surgery 21 (10.5) 9 (8.8) 12 (12.2) 0.566
Pooled results of final  
follow up
resolution of symptoms or  
improvement from baseline
164 (82) 84 (82.4) 80 (81.6) 0.895
Persistent symptoms and or  
revision surgery
36 (18) 18 (17.6) 18 (18.4) 0.895
Total number of eye  
clinic visits (sD)
4.72 (1.602) 5.06 (2.044) 4.38 (0.844) ns
Abbreviations: DCr, dacryocystorhinostomy; sD, standard deviation.
Table 4 summary of surgical success
Surgical  
results
Endonasal External Statistical 
significance
Anatomical patency 96/103 (93.2%) 83/91 (91.2%) P = 0.604
Anatomical patency  
and symptom relief
84/102 (82.4%) 80/98 (81.6%) P = 0.895Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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is always available for difficult cases or those with lacrimal 
sac tumours.9
The endoscopic approach has a reduced risk of interfering 
with the medial canthal tendon and physiology of the lacrimal 
pump mechanism. There is the advantage of no external scar, 
providing a desired cosmetic effect for patients.4 More impor-
tantly endoscopic endonasal DCR surgery has been shown 
to have earlier postoperative recovery time.10,11   Additionally, 
the Watters et al paper on long-term results for endoscopic 
DCR surgery showed lower rates of air regurgitation while 
nose blowing.12
Both surgical procedures have minimal rates of hemor-
rhage, but there is a lower to nil risk of cerebrospinal fluid 
rhinorrhea in endoscopic endonasal surgery.6,13 Dacryocysti-
tis is not a direct contraindication to the endoscopic surgery, 
and patients with chronic dacryocystitis can be treated with 
the endoscopic technique.13
The endoscopic approach allows diagnosis and manage-
ment of associated conditions. In our series, 20 patients who 
had endoscopic endonasal surgery were identified or treated 
with an associated condition, including septal deviation, sinus 
disease, and dacryocystitis. Only four patients were identified 
with an associated condition in the external DCR group. This 
difference was statistically significant (P = 0.001). Hence, 
patients with a concomitant nasal and paranasal disorder 
that may contribute to the nasolacrimal obstruction can be 
diagnosed and treated simultaneously if the endoscopic 
endonasal procedure is performed.14
Complications of endoscopic endonasal DCR are low 
but can include re-stenosis of the opening, bleeding from the 
nasal cavity, orbital injury and corneal abrasion, or canali-
culi erosion.15–17 A lacrimal sump syndrome and associated 
recurrent infections can occur if the lower portion of the bone 
surrounding the sac is removed inadequately. This can be 
avoided with a marsupialization technique used in our sur-
geries. Opening the sac inferior to the proximal nasolacrimal 
duct after bone removal can prevent this syndrome.13
Tsirbas and Wormald used a similar technique in endo-
scopic DCR to fully expose the lacrimal sac and marsupial-
ize it into the lateral nasal wall with the nasal and lacrimal 
mucosa in apposition. They achieved high long-term success 
rates with this approach at 89%.18–20
Serious complications including orbital and subcutaneous 
emphysema, retrobulbar hemorrhage, medial rectus paresis, 
and orbital fat herniation15 are rare in the medical literature 
for both forms of DCR surgery. Of the 226 patients who 
underwent endoscopic endonasal DCR in the Sonkhya ret-
rospective case series, only two patients had complications 
of orbital fat prolapse and lamina papyracea damage. Both 
had no sequele from this complication.13 We found no seri-
ous complications in our study, with only three patients with 
postoperative hemorrhage requiring conservative treatment. 
In a case series of 79 external DCRs, 14 patients had post-
operative hemorrhage compared with 0 out of 51 patients in 
the endoscopic endonasal group.21 The latter group all had 
a general anesthetic where hypotension could be achieved, 
hence most likely resulting in the lower rates of bleeding.
Endoscopic DCRs in our case series were performed with 
general anesthetic. Local anesthetic techniques have been 
reported with safe results for patients. A prospective study 
of 26 endoscopic DCRs showed no anesthetic complications 
under local anesthetic.22 Both surgical procedures can be 
performed as day only cases. A case series of warfarinized 
patients undergoing endoscopic endonasal DCR found the 
Table 6 Post operative results and complications stratified by dacryocystorhinostomy surgery, endoscopic endonasal and external
Total (205)  
Cases (%)
Endoscopic (105)  
Cases (%)
External (100)  
Cases (%)
Overall P value   
Cases (%)
Postoperative results
intra-operative complications 8 (4.3) 5 (4.8) 3 (3.7) 0.701
Change in routine treatment 26 (13.2) 11 (10.8) 15 (15.8) 0.300
Lacrimal irrigation no patency 15 (7.7) 7 (6.8) 8 (8.8) 0.604
Tubes fallen out 14 (7.3) 6 (5.9) 8 (8.8) 0.437
Adjunct surgery 17 (8.7) 11 (10.9) 6 (6.3) 0.255
Associated conditions example  
sinus disease diagnosed
24 (12.2) 20 (19.6) 4 (4.2) 0.001
referral for other pathology  
or ocular conditions
30 (15.2) 21 (20.6) 9 (9.5) 0.030
Postoperative complications
Postoperative hemorrhage 3 (1.5) 2 (2.0) 1 (1.0) 0.597
Punctal erosion 0 0 0
Canalicular obstruction 6 (3.0) 3 (2.9) 3 (3.2) 0.930Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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treatment to be safe and efficacious for treatment of distal 
nasolacrimal obstruction. The anticoagulated patients were 
not required to stop their warfarin preoperatively. This 
increases the generalizability of the procedure to a broader 
patient pool.23 All nine surgeries were performed under local 
anesthetic. In this study, a statistically significant differ-
ence in the ethnic origin was noted, where there were more 
Caucasians in the external DCR group than the endoscopic 
endonasal group. This difference may be due to the external 
group having private health insurance and the endonasal 
procedure carried out on patients in a public hospital.
Surgical success was defined as both anatomical patency 
and symptom relief in our study, giving more conservative 
results. Anatomical patency and symptom control have 
varying results in both external and endoscopic surgery 
throughout the medical literature.
Geoff Rose describes the lacrimal paradox, where 
anatomical success may not correlate to success in control 
of symptoms and vice versa. He describes the signs and 
symptoms of drainage disorders to be either volume related 
or flow related. Volume-related backwash from the lacrimal 
sac in most cases can be treated with appropriate surgery. 
However, flow-related characteristics are largely due to 
limitation or tear conductance from the lateral canthus to 
the nose. Symptom relief of flow-related symptoms is not 
achievable in every patient, especially if there is hydraulic 
resistance of the canaliculi and nasolacrimal duct.6,7
A small lacrimal punctum can cause tearing and may 
require patients to undertake a 3-snip punctoplasty. This, as 
well as ligament laxity of the eyelid and hypersecretion of 
the lacrimal gland, can also cause epiphora in patients with 
a patent functional nasolacrimal apparatus.
Endoscopic endonasal DCR has an established role in 
revision DCR surgery. Boush reported five successes in 
endoscopic revision in six primary endoscopic failures.24 
In our study, five patients underwent revision endoscopic 
endonasal DCR, with four patients having patency on irri-
gation, and of those, two patients with complete resolution 
of symptoms. Seven patients with previous external DCR 
underwent revision endonasal DCR. Patency and symptom 
resolution was achieved in four cases. Ben Simons’ case 
series of 22 revisions found similar results, with success in 
nine patients who failed the first procedure.15
It is difficult to compare success rate for primary surgery 
between external DCR and the endoscopic endonasal pro-
cedures as there are few comparative studies. Few studies 
have standard outcome measures, with some studies defining 
success as patency to irrigation with others concentrating 
on symptom resolution. Our study included both objective 
  patency results and subjective patient symptom measure-
ments. Evidence for endoscopic dacryocystorhinostomy 
appears to be comparable to the “gold standard” external 
approach, with success rates ranging from 78% to 97%. 
Refer to Table 7. A weakness in our study was that one group 
of surgical patients held private insurance, whilst the other 
procedure patients were performed in the public hospital. 
The difference in demographics may have confounded the 
outcomes, although baseline characteristic data was gathered 
for both groups.
Our findings showed a high success rate of both endo-
scopic and external approach, with 92.3% of patients show-
ing patency to irrigation and 82% showing improved or 
resolution of symptoms. There was no statistically significant 
difference between the two surgical approaches. The high 
predictability of external DCR in previous case series may 
in fact have been operator dependant rather than due to the 
surgery itself.
Endoscopic DCR are more expensive to run initially, with 
high equipment costs compared with general ophthalmol-
ogy used in external DCR.2 However, with shorter surgical 
times and use of local anesthetic in a day-surgery setting, 
these costs can be absorbed over time.2,25 The procedure is 
technically involved and can initially be difficult to learn. 
Experience with persons highly skilled with endonasal sur-
gery and endoscopic techniques is imperative, and this can 
incur higher training costs only in the short-term.10
A learning curve of the endoscopic procedure was dem-
onstrated in several studies. Onerci stratified according to 
experience of the surgeon and found high success rates of 
up to 94% with experienced surgeons, compared with inex-
perienced surgeons with success rates of only 58%.26 This 
highlights the emphasis of DCR surgery to be performed 
by ophthalmologists with an understanding of intranasal 
anatomy, perhaps with initial training together with an ENT 
(ear, nose, and throat) surgeon.
Boush and Unlu found a strong relationship between 
silicone tube retention and success, which was mirrored in 
our study.24,27 Fourteen patients who underwent DCR surgery 
had tubes that fell out before the 2-month assessment. Of 
these patients, 10 had persistent symptoms or surgical failure, 
giving a failure rate of 71%. This difference was statistically 
significant with patients whose tubes were in at the 2-month 
assessment, having a failure rate of 13.9% (P , 0.01). For 
both external and endoscopic endonasal DCR surgery having 
the silicone tube in situ for the recommended time period is 
important to achieve surgical success.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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r
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.
Conclusion
DCR is the treatment of choice for the treatment of 
  nasolacrimal duct obstruction. All studies show similar 
results in regards to external versus endoscopic surgery.
Both operations have low complication rates. The advan-
tage of endoscopic surgery is that it leaves no scar and pre-
serves the lacrimal pump system, unlike external DCR. An 
understanding of intranasal anatomy, however, is required for 
endoscopic surgery, with appropriate endoscopic training.
Choice in regards to surgical techniques should depend on 
patient preference, with consideration given on the availabil-
ity of resources amongst health care systems. The endoscopic 
endonasal approach was introduced in 1893 by Caldwell,1 
but only over the last decade have we seen the predictable 
high success rates like that of external DCR.
Endoscopic DCR surgery with its discussed benefits war-
rants a place in the 21st century as a contender for primary 
treatment of nasolacrimal duct obstruction.
Acknowledgment
The authors thank Mr Naser Ali at The Western Eye 
Hospital.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Caldwell GW. Two new operations for obstruction of the nasal duct, 
with preservation of the canaliculi, and with an incidental description 
of a new lacrimal probe. Am J Ophthalmol. 1893;10:189–193.
  2.  Tarbet KJ, Custer PL. External dacryocystorhinostomy: surgical suc-
cess, patient satisfaction, and economic cost. Ophthalmology. 1995;102: 
1065–1070.
  3.  Yung MW, Hardman-Lea S. Analysis of the results of surgical 
endoscopic.
  4.  Durvasula V, Gatland DJ. Endoscopic dacryocystorhinostomy:long-
term results and evolution of surgical technique. J Laryngol Otol. 2004; 
118:628–632.
  5.  Dolman PJ. Comparison of external dacryocystorhinostomy with non-
laser endonasal dacryocystorhinostomy. Ophthalmology. 2003;110(1): 
78–84.
  6.  Guthoff RF, Katowitz JA. Essentials in Ophthalmology: Oculoplastics 
and Orbit, The Apparent Paradox of “Success” in Lacrimal Drainage 
Surgery. 3rd ed. Berlin: Springer; 2005.
  7.  Rose GE. The lacrimal paradox: towards a greater understanding of 
success in lacrimal surgery. Ophthal Plast Reconstr Surg. 2004;20: 
262–265.
  8.  Shun-Shin GA, Thurairajan G. External dacryocystorhinostomy – an 
end of an era? Br J Ophthalmol. 1997;81:716–717.
  9.  Zhou W, Zhou M, Li Z, Wang T. Endoscopic intranasal dacryocystorhinos-
tomy in forty-five patients. Chin Med J (Engl). 1996;109:747–748.
  10.  Watters GWR, Whittet HB, Shun-shin GA, Milford CA. Endoscopic 
transnasal dacryocystorhinostomy – long-term results. Minim Invasive 
Ther Allied Technol. 1996;5:505–510.
  11.  Metson R. Endoscopic surgery for lacrimal obstruction. J Otolaryngol 
Head Neck Surg. 1991;104:473–479.Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
989
external and endoscopic endonasal dacryocystorhinostomy
  12.  Watters GWR, Whittet HB, Shun-Shin GA, Milford CA. Endoscopic 
transnasal dacryocystorhinostomy long term results. Min Invas Ther 
Allied Technol. 1996;5:505–510.
  13.  Sonkhya N, Mishra P. Endoscopic transnasal dacryocystorhinostomy 
with nasal mucosal and posterior lacrimal sac flap. J Laryngol Otol. 
2009;123(3):320–326.
  14.  Royal Australasian College of Surgeons. New and Emerging 
  Techniques – Surgical Rapid Review: Endoscopic Dacryocystorhi-
nostomy. North Adelaide, Australia: Australian Safety and Efficacy 
Register of New Interventional Procedures – Surgical; 2003.
  15.  Ben Simon GJ, Joseph J, Lee S, Schwarcz RM, McCann JD, 
  Goldberg RA. External versus endoscopic dacryocystorhinostomy 
for acquired nasolacrimal duct obstruction in a tertiary referral center. 
  Ophthalmology. 2005;112:1463–1468.
  16.  Woog JJ, Kennedy RH, Custer PL, Kaltreider SA, Meyer DR, 
Camara JG. Endonasal dacryocystorhinostomy. Ophthalmology. 
2001;108: 2369–2377.
  17.  Agarwal S. Endoscopic dacryocystorhinostomy for acquired nasolac-
rimal duct obstruction. J Laryngol Otol. 2009;123:1226–1228.
  18.  Tsirbas A, Wormald PJ. Endonasal dacryocystorhinostomy with 
mucosal flaps. Am J Ophthalmol. 2003;135:76–83.
  19.  Tsirbas A, Wormald PJ. Mechanical endonasal dacryocystorhinostomy 
with mucosal flaps. Br J Ophthalmol. 2003;87:43–47.
  20.  Wormald PJ. Powered endoscopic dacryocystorhinostomy.   Laryngoscope. 
2002;112:69–72.
  21.  Cokkeser Y, Evereklioglu C, Er H. Comparative externalversus 
endoscopic dacryocystorhinostomy: result in 115 patients (130 eyes). 
Otolaryngol Head Neck Surg. 2000;123:488–491.
  22.  Howden J, McCluskey P, O’Sullivan G, Ghabrial R. Assisted local 
anaesthesia for endoscopic dacryocystorhinostomy. Clin Experiment 
Ophthalmol. 2007;35:256–261.
  23.  Smith W, Merkonidis C, Draper M, Yung M. Endoscopic dacryocys-
torhinostomy in warfarinized patients. Am J Otolaryngol Head Neck 
Med Surg. 2006;27:327–329.
  24.  Boush GA, Lemke BN, Dortzbach RK. Results of endonasal laser-
assisted dacryocystorhinostomy. Ophthalmology. 1994;101:955.
  25.  Hartikainen J, Antila J, Varpula M, Puukka P, Seppa H, Grenman R. 
Prospective randomised comparison of endonasal endoscopic dacryo-
cystorhinostomy and external dacryocystorhinostomy. Laryngoscope. 
1998;108:1861–1866.
  26.  Onerci M. Dacryocystorhinostomy. Diagnosis and treatment of nasolac-
rimal canal obstructions. Rhinology. 2002;40(2):49–65.
  27.  Unlu HH, Toprak B, Aslan A, Guler C. Comparison of surgical out-
comes in primary endoscopic dacryocystorhinostomy with and without 
silicone intubation. Ann Otol Rhinol Laryngol. 2002;111:704–709.
  28.  Leong SC, Macewen CJ, White PS, A systematic review of   outcomes 
after dacryocystorhinostomy in adults. Am J Rhinol Allergy. 2010;24(1): 
81–90.
  29.  Sharma BR. Non endoscopic endonasal dacryocystorhinostomy versus 
external Dacryocystorhinostomy. Kathmandu Univ Med J. 2008;6(24): 
437–442.
  30.  Jin HR, Yeon JY, Choi MY. Endoscopic dacryocystorhinostomy: 
  creation of a large marsupialized lacrimal sac. J Korean Med Sci. 2006; 
21(4):719–723.
  31.  Nussbaumer M, Schreiber S, Yung MW. Concomitant nasal procedures 
in endoscopic dacryocystorhinostomy. J Laryngol Otol. 2004;118: 
267–269.
  32.  Moore WM, Bentley CR, Olver JM. Functional and anatomic results 
after two types of endoscopic endonasal dacryocystorhinostomy: surgi-
cal and holmium laser. Ophthalmology. 2002;109:1575–1582.
  33.  Zilelioglu G, Tekeli O, Ugurba SH, Akiner M, Akturk T, Anadolu Y. 
Results of endoscopic endonasalnon-laser dacryocystorhinostomy. Doc 
Ophthalmol. 2002;105:57–62.
  34.  Fayet B, Racy E, Assouline M. Systematic unciformectomy for a stan-
dardized endonasal dacryocystorhinostomy. Ophthalmology. 2002;109: 
530–536.
  35.  Onerci M, Orhan M, Ogretmenoğlu O, Irkec M. Long-term results and 
reasons for failure of intranasal endoscopic dacryocystorhinostomy. 
Acta Otolaryngol. 2000;120(2):319–322.
  36.  Watters GWR, Whittet HB, Shun-shin GA, Milford CA, Endoscopic 
transnasal dacryocystorhinostomy -long-term results. Minimally Inva-
sive Therapy and Allied Technologies. 1996;5(6):505–510.
  37.  Pandya VB, Lee S, Benger R, et al. External dacryocystorhinos-
tomy: assessing factors that influence outcome. Orbit. 2010;29(5): 
291–297.
  38.  Delaney YM, Khooshabeh R. External dacryocystorhinostomy for 
the treatment of acquired partial nasolacrimal obstruction in adults. 
Br J Ophthalmol. 2002;86:533–553.
  39.  Feretis M, Newton JR, Ram B. Comparison of external and endonasal 
dacryocystorhinostomy. J Laryngol Otol. 2009;123(3):315–319.
  40.  Leong SC, Karkos PD, Burgess P, Halliwell M, Hampal S. A compari-
son of outcomes between nonlaser endoscopic endonasal and external 
dacryocystorhinostomy: single-center experience and a review of British 
trends. Am J Otolaryngol. 2010;31(1):32–37.
  41.  Maini S, Raghava N, Youngs R et al. Endoscopic endonasal laser 
versus endonasal surgical dacryocystorhinostomy for epiphora due to 
nasolacrimal duct obstruction: prospective, randomised, controlled trial. 
J Laryngol Otol. 2007;121(12):1170–1176.